Plasma metabolomic profiles in liver cancer patients following stereotactic body radiotherapy

BACKGROUND: Stereotactic body radiotherapy (SBRT) is an effective treatment for hepatocellular carcinoma (HCC). This study sought to identify differentially expressed plasma metabolites in HCC patients at baseline and early during SBRT, and to explore if changes in these metabolites early during SBR...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Sylvia S.W., Jang, Gun Ho, Kurland, Irwin J., Qiu, Yunping, Guha, Chandan, Dawson, Laura A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484529/
https://www.ncbi.nlm.nih.gov/pubmed/32891936
http://dx.doi.org/10.1016/j.ebiom.2020.102973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484529/
https://www.ncbi.nlm.nih.gov/pubmed/32891936
http://dx.doi.org/10.1016/j.ebiom.2020.102973

Ejemplares similares